CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies
Dongrui Wang(Zhejiang Chinese Medical University), Jeremy N. Rich(University of North Carolina at Chapel Hill), Christine E. Brown(City Of Hope National Medical Center), Alfonso Brito(City of Hope), Qiulian Wu(University of California San Diego), Briana C. Prager(University of California San Diego), Stephen J. Forman(City Of Hope National Medical Center), Hongzhen Tang(Westlake University), Ryan C. Gimple(Washington University in St. Louis), Renate Starr(City of Hope), Behnam Badie(City Of Hope National Medical Center), Deguan Lv(University of Pittsburgh), Leo J.Y. Kim(University of California San Diego), Zhixin Qiu(University of California San Diego), Qi Xie(Westlake University), Michael H. Lorenzini(University of California San Diego), Darya Alizadeh(CTI BioPharma (United Kingdom)), Brenda Aguilar(City of Hope)
Cited by 177
Related Papers
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
|Clinical Cancer Research|2015|754